These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin. Gentry LO, Zeluff BJ, Cooley DA. Ann Thorac Surg; 1988 Aug; 46(2):167-71. PubMed ID: 3401076 [Abstract] [Full Text] [Related]
8. Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors. Edwards WH, Kaiser AB, Tapper S, Edwards WH, Martin RS, Mulherin JL, Jenkins JM, Roach AC. J Vasc Surg; 1993 Sep; 18(3):470-5; discussion 475-6. PubMed ID: 8377241 [Abstract] [Full Text] [Related]
9. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. Kernodle DS, Classen DC, Burke JP, Kaiser AB. JAMA; 1990 Feb 16; 263(7):961-6. PubMed ID: 2299764 [Abstract] [Full Text] [Related]
10. Prophylaxis in cardiac surgery. A controlled randomized comparison between cefazolin and cefuroxime. Wellens F, Pirlet M, Larbuisson R, De Meireleire F, De Somer P. Eur J Cardiothorac Surg; 1995 Feb 16; 9(6):325-9. PubMed ID: 7546806 [Abstract] [Full Text] [Related]
11. Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization. Stone PA, AbuRahma AF, Campbell JR, Hass SM, Mousa AY, Nanjundappa A, Srivastiva M, Modak A, Emmett M. Ann Surg; 2015 Sep 16; 262(3):495-501; discussion 500-1. PubMed ID: 26258318 [Abstract] [Full Text] [Related]